Curt Oltmans

Adjunct Faculty

401 UCB
2450 Kittredge Loop Drive
Wolf Law Building
Boulder, CO  80309

Mr. Oltmans joined DaVita Inc. as Vice President, Head of Litigation in June 2019. This role includes government investigations, civil litigation, certain internal and international investigations, records retention, employee safety and the insurance portfolio. Mr. Oltmans served as Executive Vice President, General Counsel and Secretary at Array BioPharma Inc., in Boulder, Colorado, from August 2017 until March 2019. Prior to joining Array, Mr. Oltmans served as Corporate Vice President and General Counsel, North America, at Novo Nordisk, Inc., a fully integrated global healthcare company, where he was responsible for strategy and initiatives in the areas of law, including intellectual property and litigation, communications, quality, and public affairs for the company?s substantial business in North America. Prior to Novo Nordisk, Mr. Oltmans spent 13 years at Eli Lilly and Company in a variety of legal roles, including litigation, FDA regulatory and international law. Mr. Oltmans was an associate at Shook, Hardy & Bacon from 1989 to 1992.


Spring 2021 Investigations LAWS 9223-901
Fall 2020 Investigations LAWS 9223-901
Spring 2020 Topics in Compliance LAWS 9222-901
Spring 2019 Topics in Compliance LAWS 9222-901